bell
The current prices are delayed by 15 mins, login to check live prices.
Alembic Ltd share price logo

Alembic Ltd

(ALEMBICLTD)

₹123.261.6%

as on 04:01PM, 21 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Alembic Ltd Performance

  • Day's Low

    Day's High

    ₹122.19
    ₹125.5
  • 52 Week's Low

    52 Week's High

    ₹78.1
    ₹169
1 Month Return-1.66 %
3 Month Return-16.95 %
1 Year Return+ 52.94 %
Previous Close₹125.26
Open₹124.79
Volume4.52L
Upper Circuit-
Lower Circuit-
Market Cap₹3,216.45Cr

Alembic Ltd Key Statistics

P/E Ratio10.37
PEG Ratio3.28
Market Cap₹3,216.45 Cr
P/B Ratio2.66
EPS3.62
Dividend Yield2.87
SectorRealty
ROE11.34

Alembic Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹3,216.45 Cr28.6%0.51₹92 Cr₹157 Cr
NA₹50.26 Cr-16.1%0.90-₹50 Cr₹27 Cr
NA₹31.25 Cr-1.31%0.53NANA
BUY₹2,720.96 Cr11.21%0.80-₹68 Cr₹1,371 Cr
NA₹101.23 Cr3.85%0.54₹5 Cr₹45 Cr

About Alembic Ltd

Alembic Ltd is one of India's most experienced manufactures of bulk drugs, pharmaceuticals, and formulations in human and animal healthcare. With a 100-year legacy of operations, they are committed to continually improving the quality of life and healthcare in over 75 countries worldwide. The ISO9002 and ISO14001 certified company manufacturing practices and facilities follow WHOGMP guidelines. Their product range include medicines, chemicals, bulk drugs such as penicillin, other antibiotics, and formulations. With factories in Vadodara, Gujarat, and Solan, Himachal Pradesh, the company has seen tremendous success over the years. From establishing a penicillin plant in 1961, launching of the top selling Erythromycin brand Althrocin in 1972 to manufacturing Cephalosporin C in 2001, Zero - a new generation no calories Sucralose Based Sugar Substitute in 2005, and setting up a formulation manufacturing facility in Baddi with a capacity of 900 million tablets and 600 liquid oral bottles in 2017, Alembic Ltd and its offerings have grown exponentially. Last year, the company acquired the Non-Oncology Business of Dabur Pharma Ltd and entered into a licensing agreement with UCB Belgium while adding new API facilities.

Share Price: ₹123.26 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹3,216.45Cr as of today
Revenue: ₹52.91Cr as on September 2024 (Q3 24)
Net Profit: ₹77.31Cr as on September 2024 (Q3 24)
Listing date: 04 Jan, 1995
Chairperson Name: Chirayu R Amin
OrganisationAlembic Ltd
HeadquartersVadodara
IndustryRealty
E-voting on sharesClick here to vote

Key events for Alembic Ltd

  • Alembic Reports Strong Q3 Growth in Sales and Profit - 18 Nov, 2024

    Alembic Ltd reported a 64.03% increase in net sales to Rs 51.10 crore for September 2024, with net profit rising 48.92% to Rs 76.60 crore. EBITDA also grew by 46.09%. The EPS increased to Rs 2.98. Alembic shares have shown significant returns of 26.30% over the last 6 months and 55.51% over the last year.

  • Alembic Pharmaceuticals Secures USFDA Approval and Reports Growth - 11 Nov, 2024

    Alembic Pharmaceuticals received USFDA approval for Diltiazem Hydrochloride capsules, indicated for hypertension. The company also reported significant growth in net sales and profits for September 2024.

Insights on Alembic Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.42% to 1.96% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 55.82 Cr → 121.02 Cr (in ₹), with an average increase of 53.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 41.55 Cr → 118.51 Cr (in ₹), with an average increase of 25.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 5.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 103.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.88% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 27.64% to 27.06% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ALEMBICLTD stock has moved down by -17.0%

Alembic Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹32.28Cr (-)₹39.32Cr (↑21.81%)₹49.04Cr (↑24.72%)₹50.78Cr (↑3.55%)₹52.91Cr (↑4.19%)
Net Income₹51.70Cr (-)₹9.91Cr (↓80.83%)₹21.29Cr (↑114.83%)₹17.42Cr (↓18.18%)₹77.31Cr (↑343.80%)
Net Profit Margin160.16% (-)25.20% (↓84.27%)43.41% (↑72.26%)34.30% (↓20.99%)146.12% (↑326.01%)
Value in ₹ crore
Details2021202220232024
Total Assets₹939.53Cr (-)₹1,148.35Cr (↑22.23%)₹955.14Cr (↓16.83%)₹950.29Cr (↓0.51%)
Total Liabilities₹112.71Cr (-)₹134.50Cr (↑19.33%)₹126.15Cr (↓6.21%)₹141.53Cr (↑12.19%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹5.48Cr (-)-₹1.12Cr (↓120.44%)-₹21.87Cr (↑1,852.68%)₹34.70Cr (↓258.66%)₹25.33Cr (↓27.00%)

Index Inclusions

BSE Small-Cap

₹52,141.15

-0.67 (-349.79%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Alembic Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
70.88%
0.00
Foreign Institutions
1.96%
38.01
Mutual Funds
0%
0.00
Retail Investors
27.06%
-2.10
Others
0.09%
75.05

Alembic Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)3.620.543.363.143.62
Details20202021202220232024
Return On Equity %20.891.479.318.611.34
Details20202021202220232024
Return On Assets %61.2136.4919.3419.9628.27
Details20202021202220232024
Book Value Per Share (₹)55.2289.4597.2380.9385.11

Alembic Ltd Valuation

Alembic Ltd in the last 5 years

  • Overview

  • Trends

Lowest (2.82x)

March 31, 2020

Today (10.37x)

November 19, 2024

Industry (129.60x)

November 19, 2024

Highest (15.06x)

August 23, 2024

LowHigh

Alembic Ltd Earnings and Dividends

  • Alembic Ltd Earnings Results

    Alembic Ltd’s net profit jumped 33.46% since last year same period to ₹121.02Cr in the Q2 2024-2025. On a quarterly growth basis, Alembic Ltd has generated 116.8% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Alembic Ltd Dividends May,2024

    In the quarter ending March 2024, Alembic Ltd has declared dividend of ₹2.40 - translating a dividend yield of 1.92%.

    Read More about Dividends

Alembic Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Alembic Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Alembic Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Alembic Ltd shares.

Alembic Ltd (ALEMBICLTD) share price today is ₹123.26

Alembic Ltd is listed on NSE

Alembic Ltd is listed on BSE

  • Today’s highest price of Alembic Ltd is ₹125.5.
  • Today’s lowest price of Alembic Ltd is ₹122.19.

PE Ratio of Alembic Ltd is 10.37

PE ratio = Alembic Ltd Market price per share / Alembic Ltd Earnings per share

Today’s traded volume of Alembic Ltd(ALEMBICLTD) is 4.52L.

Today’s market capitalisation of Alembic Ltd(ALEMBICLTD) is ₹3216.45Cr.

Alembic Ltd(ALEMBICLTDPrice
52 Week High
₹169
52 Week Low
₹78.1

Alembic Ltd(ALEMBICLTD) share price is ₹123.26. It is down -27.07% from its 52 Week High price of ₹169

Alembic Ltd(ALEMBICLTD) share price is ₹123.26. It is up 57.82% from its 52 Week Low price of ₹78.1

Alembic Ltd(ALEMBICLTDReturns
1 Day Returns
-2%
1 Month Returns
-1.66%
3 Month Returns
-16.95%
1 Year Returns
52.94%